Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchhumaninketaminedepressionmitochondria

Review proposes ketamine lifts humanin to restore astrocyte mitochondria

The hypothesis-driven overview in Alpha Psychiatry places mitochondrial peptide signalling, not synaptic NMDA receptor blockade, at the centre of ketamine's antidepressant effect.

PR
By Priya Raman · Science Reporter
Aug 23 20:00 ETSource: Alpha psychiatry

The wire

  1. 01Anderson and colleagues argue ketamine's antidepressant efficacy arises from direct effects on astrocyte mitochondria, with upregulation of adenosine, humanin and melatonin at stress-vulnerable sites.
  2. 02Humanin is among the mitochondrial-derived peptides readers track for longevity and neuroprotection; the paper frames it as a downstream mediator of an established psychiatric drug.
  3. 03This is a literature review and hypothesis paper, not new experimental data; the proposed inner-mitochondrial-membrane NMDA receptor mechanism remains untested.

From the source

Low Dose Ketamine Preconditions Astrocyte Mitochondria to Achieve Antidepressant Efficacy via Adenosine, Humanin, and Melatonin Upregulation and Efflux

Alpha psychiatry · 2026 Aug · Anderson G et al.

Read at pubmed.ncbi.nlm.nih.gov